We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Marker for Illness and Disease

By HospiMedica staff writers
Posted on 12 Aug 2004
A condition called metabolic syndrome has been found to be closely linked to breast and prostate cancer as well as diabetes, cardiovascular disease, chronic liver disease, and sleep apnea. More...


Diagnosing the condition so that treatment could begin would greatly help to reduce the incidence of illness and disease, since the condition affects more than 25% of all people in the United States. Diagnosis is fairly simple, since those people at risk will have three of the following traits: waist measurement of 40 inches or more among men and 35 inches or more among women, blood triglyceride levels of 150 or greater, blood pressure of 130/83 or higher, and fasting blood sugar of 100 or more. The incidence of metabolic syndrome appears to be higher among people of lower socioeconomic status. Treatment consists mainly of lifestyle changes, such as a vigorous physical fitness program and good nutrition, according to the authors.

The incidence of heart risk associated with metabolic syndrome could be reduced by as much as 10%, and the incidence of diabetes could be reduced by as much as 35%, according to the study conducted by Earl S. Ford, M.D., MPH, of the (U.S.) National Center for Chronic Disease Prevention and Control (Atlanta, GA, USA).

A second study was conducted by Gerald Reaven, M.D., of Stanford University (Palo Alto, CA, USA), who was the first to identify metabolic syndrome. According to Dr. Reaven, the condition also leads to hypertension. His report concludes that a person who is more physically fit will produce appropriate levels of insulin and be less likely to develop metabolic syndrome.

Both studies were presented at the annual meeting of the American Association of Clinical Chemistry in Los Angeles (CA, USA) in July 2004.




Related Links:
National Center for Chronic Disease
Stanford U.

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.